

Allogeneic transplant in first remission for post-induction molecular MRD; circulating HSPCs actively participate in human hematopoiesis; let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching
May 9, 2024
Exploring allogeneic transplant benefits for AML patients based on MRD, let-7 miRNAs role in BCL11A transcription, and the contribution of circulating HSPCs in hematopoiesis.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Retrospective Analysis of Allogeneic Transplant in NPM1-Mutated AML Patients in Remission
03:01 • 3min
Study on MRD Monitoring and Aloe HSTT Benefits in AML Patients
05:58 • 2min
Exploring Circulating Hematopoietic Stem Progenitor Cells
07:47 • 7min
Exploring the Role of Let7 miRNAs in Hemoglobin Switching
14:36 • 7min